NewGenIvf Group (NASDAQ:NIVF) Stock to Reverse Split on Monday, July 6th

Shares of NewGenIvf Group Limited (NASDAQ:NIVF) are set to reverse split on the morning of Monday, July 6th. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, July 5th.

NewGenIvf Group Stock Performance

Shares of NASDAQ NIVF traded down $0.09 during midday trading on Thursday, hitting $0.46. 876,271 shares of the company’s stock were exchanged, compared to its average volume of 11,033,116. The firm’s fifty day simple moving average is $0.97 and its 200-day simple moving average is $3.34. NewGenIvf Group has a twelve month low of $0.43 and a twelve month high of $295.17. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings results on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million during the quarter. On average, sell-side analysts anticipate that NewGenIvf Group will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Monday, April 27th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

Insider Activity

In other NewGenIvf Group news, major shareholder Financial Lp Hrt bought 137,541 shares of the stock in a transaction dated Friday, May 22nd. The shares were acquired at an average cost of $0.99 per share, for a total transaction of $136,165.59. Following the completion of the transaction, the insider owned 111,885 shares in the company, valued at approximately $110,766.15. The trade was a -536.10% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 31.80% of the company’s stock.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.